198 related articles for article (PubMed ID: 21306188)
21. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function.
Tanaka S; Maeda S; Hashimoto M; Fujimori C; Ito Y; Teradaira S; Hirota K; Yoshitomi H; Katakai T; Shimizu A; Nomura T; Sakaguchi N; Sakaguchi S
J Immunol; 2010 Aug; 185(4):2295-305. PubMed ID: 20644168
[TBL] [Abstract][Full Text] [Related]
22. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
23. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
[TBL] [Abstract][Full Text] [Related]
24. Essential roles of TGF-beta in anti-CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
J Leukoc Biol; 2008 Feb; 83(2):280-7. PubMed ID: 18029395
[TBL] [Abstract][Full Text] [Related]
25. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
[TBL] [Abstract][Full Text] [Related]
26. Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.
You S; Slehoffer G; Barriot S; Bach JF; Chatenoud L
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14580-5. PubMed ID: 15340148
[TBL] [Abstract][Full Text] [Related]
27. Effects of in vivo injection of anti-chicken CD25 monoclonal antibody on regulatory T cell depletion and CD4+CD25- T cell properties in chickens.
Shanmugasundaram R; Selvaraj RK
Dev Comp Immunol; 2012 Mar; 36(3):578-83. PubMed ID: 22004798
[TBL] [Abstract][Full Text] [Related]
28. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice.
Yagi H; Matsumoto M; Kunimoto K; Kawaguchi J; Makino S; Harada M
Eur J Immunol; 1992 Sep; 22(9):2387-93. PubMed ID: 1516628
[TBL] [Abstract][Full Text] [Related]
31. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
32. Regulatory T cells restrain CD4+ T cells from causing unregulated immune activation and hypersensitivity to lipopolysaccharide challenge.
Okeke EB; Okwor I; Uzonna JE
J Immunol; 2014 Jul; 193(2):655-62. PubMed ID: 24943218
[TBL] [Abstract][Full Text] [Related]
33. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
[TBL] [Abstract][Full Text] [Related]
34. Dietary protection against diabetes in NOD mice: lack of a major change in the immune system.
Hermitte L; Atlan-Gepner C; Payan MJ; Mehelleb M; Vialettes B
Diabete Metab; 1995 Oct; 21(4):261-8. PubMed ID: 8529761
[TBL] [Abstract][Full Text] [Related]
35. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x.
Lamhamedi-Cherradi SE; Luan JJ; Eloy L; Fluteau G; Bach JF; Garchon HJ
Diabetologia; 1998 Feb; 41(2):178-84. PubMed ID: 9498651
[TBL] [Abstract][Full Text] [Related]
36. Both CD4(+) T cells and CD8(+) T cells are required for iodine accelerated thyroiditis in NOD mice.
Hutchings PR; Verma S; Phillips JM; Harach SZ; Howlett S; Cooke A
Cell Immunol; 1999 Mar; 192(2):113-21. PubMed ID: 10087179
[TBL] [Abstract][Full Text] [Related]
37. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
[TBL] [Abstract][Full Text] [Related]
38. Dynamic changes of CD4+CD25 + regulatory T cells in NOD.H-2h4 mice with iodine-induced autoimmune thyroiditis.
Xue H; Wang W; Shan Z; Li Y; Li Y; Teng X; Gao Y; Fan C; Teng W
Biol Trace Elem Res; 2011 Oct; 143(1):292-301. PubMed ID: 20820943
[TBL] [Abstract][Full Text] [Related]
39. CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.
Mariño E; Villanueva J; Walters S; Liuwantara D; Mackay F; Grey ST
Diabetes; 2009 Jul; 58(7):1568-77. PubMed ID: 19336675
[TBL] [Abstract][Full Text] [Related]
40. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice.
Noorchashm H; Noorchashm N; Kern J; Rostami SY; Barker CF; Naji A
Diabetes; 1997 Jun; 46(6):941-6. PubMed ID: 9166663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
